AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +200.0% | 573 | +48.4% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -99.5% | 386 | -99.6% | 0.00% | -100.0% |
| Q4 2022 | $195 | -99.9% | 97,810 | -0.2% | 0.01% | -10.0% |
| Q3 2022 | $198,000 | -36.5% | 97,970 | -0.3% | 0.01% | -28.6% |
| Q2 2022 | $312,000 | -49.4% | 98,236 | -33.4% | 0.01% | -41.7% |
| Q1 2022 | $616,000 | +13.4% | 147,518 | +30.0% | 0.02% | +41.2% |
| Q4 2021 | $543,000 | -13.3% | 113,439 | -3.3% | 0.02% | -15.0% |
| Q3 2021 | $626,000 | +2.0% | 117,255 | -2.4% | 0.02% | 0.0% |
| Q2 2021 | $614,000 | -24.0% | 120,182 | +0.1% | 0.02% | -31.0% |
| Q1 2021 | $808,000 | +16060.0% | 120,020 | +10264.4% | 0.03% | – |
| Q4 2020 | $5,000 | +25.0% | 1,158 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -33.3% | 1,158 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | – | 1,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |